{"DataElement":{"publicId":"5152531","version":"1","preferredName":"Product Alteration Recognition Specified Target Performed Type","preferredDefinition":"A description of the specific target that the product was altered to recognize.","longName":"5152493v1.0:5152495v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5152493","version":"1","preferredName":"Product Alteration Recognition Specified Target Performed","preferredDefinition":"A thing produced by or resulting from a process. EXAMPLE(S): drug, device. The FDA list of regulated products: animal and human drugs; therapeutic biologics; allergenics; cell, tissue and gene therapy products; blood components; blood derivative products; devices; and animal (pets and livestock) and human food/feed (medicated and un-medicated); cosmetics; pet treats; and dietary supplements._A change resulting in something that is different from the original._The act of seeing something as familiar._Clearly and explicitly stated._An object fixed as a goal or point of examination; something to point at; a destination._Executed and carried through to completion.","longName":"5152391v1.0:5152491v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5152391","version":"1","preferredName":"Product Alteration","preferredDefinition":"The end result of a manufacturing process; anything that is produced.:A change resulting in something that is different from the original.","longName":"C51980:C28344","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Product","conceptCode":"C51980","definition":"The end result of a manufacturing process; anything that is produced.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Alteration","conceptCode":"C28344","definition":"The act or process of modifying something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D7ABEB3-F6E0-5A27-E050-BB89AD43103F","latestVersionIndicator":"Yes","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"ONEDATA","dateModified":"2016-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5152491","version":"1","preferredName":"Recognition Specified Target Performed","preferredDefinition":"The act of seeing something as familiar.:Clearly and explicitly stated.:An object fixed as a goal or point of examination; something to point at; a destination.:Executed and carried through to completion.","longName":"C86585:C38024:C25702:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recognition","conceptCode":"C86585","definition":"The act of seeing something as familiar.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Specified","conceptCode":"C38024","definition":"Clearly and explicitly stated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D7D1139-6EC5-D0F1-E050-BB89AD436F4C","latestVersionIndicator":"Yes","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"ONEDATA","dateModified":"2016-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D7D1139-6ED6-D0F1-E050-BB89AD436F4C","latestVersionIndicator":"Yes","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"NYCHM","dateModified":"2016-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5152495","version":"1","preferredName":"Specified Target Type","preferredDefinition":"Clearly and explicitly stated._An object fixed as a goal or point of examination; something to point at; a destination._Something distinguishable as an identifiable class based on common qualities.","longName":"5152495v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Tumor / cancer antigen","valueDescription":"Neoplasm And/Or Malignant Neoplasm Antigen Target","ValueMeaning":{"publicId":"5152511","version":"1","preferredName":"Neoplasm And/Or Malignant Neoplasm Antigen Target","longName":"5152511","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: Used to indicate that either or both of two items or options may be valid.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.: An object fixed as a goal or point of examination; something to point at; a destination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Antigen","conceptCode":"C268","definition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D7DD38B-0746-ACB4-E050-BB89AD43114E","latestVersionIndicator":"Yes","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2D7DD38B-075F-ACB4-E050-BB89AD43114E","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"ONEDATA","dateModified":"2016-03-07","deletedIndicator":"No"},{"value":"Other target","valueDescription":"Other Target","ValueMeaning":{"publicId":"5152512","version":"1","preferredName":"Other Target","longName":"5152512","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An object fixed as a goal or point of examination; something to point at; a destination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D7DD38B-0769-ACB4-E050-BB89AD43114E","latestVersionIndicator":"Yes","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2D7DD38B-0782-ACB4-E050-BB89AD43114E","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"ONEDATA","dateModified":"2016-03-07","deletedIndicator":"No"},{"value":"Viral","valueDescription":"Viral Target","ValueMeaning":{"publicId":"5152496","version":"1","preferredName":"Viral Target","longName":"5152496","preferredDefinition":"Having to do with a virus.: An object fixed as a goal or point of examination; something to point at; a destination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral","conceptCode":"C27985","definition":"Having to do with a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D7D1139-6F17-D0F1-E050-BB89AD436F4C","latestVersionIndicator":"Yes","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2D7D1139-6F30-D0F1-E050-BB89AD436F4C","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"ONEDATA","dateModified":"2016-03-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5152494","version":"1","preferredName":"Specified Target Type","preferredDefinition":"Clearly and explicitly stated.:An object fixed as a goal or point of examination; something to point at; a destination.:Something distinguishable as an identifiable class based on common qualities.","longName":"C38024:C25702:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specified","conceptCode":"C38024","definition":"Clearly and explicitly stated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D7D1139-6EED-D0F1-E050-BB89AD436F4C","latestVersionIndicator":"Yes","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"ONEDATA","dateModified":"2016-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D7D1139-6EFE-D0F1-E050-BB89AD436F4C","latestVersionIndicator":"Yes","beginDate":"2016-03-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-07","modifiedBy":"NYCHM","dateModified":"2016-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set – Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"CTI_CPM_prd_manip_rec_tgt_ty","type":"NMDP_FN","context":"NHLBI"},{"name":"CTP_CPM_prd_manip_rec_tgt_ty","type":"NMDP_FN","context":"NHLBI"},{"name":"Biologic:typeCode","type":"HCT_BRIDG_5","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the specific target","type":"Preferred Question Text","description":"What was the specific target that the product was altered to recognize?","url":null,"context":"NHLBI"},{"name":"Specify target","type":"Alternate Question Text","description":"Specify target","url":null,"context":"NHLBI"},{"name":"Specify target","type":"Application Standard Question Text","description":"Specify target","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D8AD116-49E4-BAFA-E050-BB89AD434F0E","latestVersionIndicator":"Yes","beginDate":"2016-03-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-08","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":"Added HCT_BRIDG5 alternate name - RR 2018-12-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}